Apolipoprotein B (APOB)-containing very LDL (VLDL) production, secretion, and clearance by hepatocytes is a central determinant of hepatic and circulating lipid levels. Impairment of any of the aforementioned processes is associated with the development of multiple diseases. Despite the discovery of genes and processes that govern hepatic VLDL metabolism, our understanding of the different mechanistic steps involved is far from complete. An impediment to these studies is the lack of tractable hepatocyte-based systems to interrogate and follow APOB in cells, which the current study addresses.


You can read the full story here!

Share this message

Latest news Medical Biochemistry Amsterdam

February 18, 2026
Discovery of Pathogenic Signaling Cascade in  Capillary Malformations
By Marten Hoeksema February 16, 2026
Our most recent work showing an alternative pathway activated by interferons in macrophages, now published online in Cell Reports:
Show More